Current Positions
Dr Franz Humer is currently an Independent Director of Allogene Therapeutics, Chairman of PCI Services Inc., Advisory Board member of LetterOne Holdings, Senior Advisor to Target PharmaSolutions (a data-solutions company for the pharmaceutical and biotech industries), Healthcare Advisor to Temasek Holdings (Singapore) and Advisor to a number of start-up companies.
Industry Knowledge
Professional experience from positions in the pharmaceuticals industry at, among others, Schering Plough Corp. and Roche Holdings Ltd. In March 2014, Franz retired as Chairman of Roche Holding AG, capping a transformative 15-year tenure as Chairman and/or Chief Executive Officer.
Franz was also Chairman of Diageo, the world’s leading spirits company, and an Independent Director with Citigroup Inc., Chugai Pharmaceuticals Ltd (Japan), Arix Bioscience plc and Kite Pharma (biotech company in Los Angeles).